- call +1-201-465-4211
- email sales@mrinsights.biz
Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact.
Scope of the Report:
This report focuses on the MRSA Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Methicillin-resistant Staphylococcus aureus (MRSA) is a skin infection that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and is highly contagious. This infection is difficult to treat because it is sometimes resistant to commonly-used antibiotics such as methicillin. As per this market research report, the aging people are highly susceptible to MRSA infections, especially in the hospital environment as their weak immune system makes them easily prone to diseases and infections.
The worldwide market for MRSA Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Allergan
Merck
Pfizer
Theravance Biopharma
Absynth Biologics
AmpliPhi Biosciences
AstraZeneca
Basilea Pharmaceutica
Baxter
Cellceutix
Cempra
CrystalGenomics
Debiopharm
Galapagos
GSK
KYORIN Pharmaceutical
Lytix Biopharma
Melinta Therapeutics
Nabriva Therapeutics
NovaDigm Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tetracycline
Folate antagonist
Cephalosporin
Lipopeptides
Oxazolidinone
Lipoglycopeptide
Market Segment by Applications, can be divided into
Hospital
Research
Clinic
Other
There are 15 Chapters to deeply display the global MRSA Drugs market.
Chapter 1, to describe MRSA Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of MRSA Drugs, with sales, revenue, and price of MRSA Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of MRSA Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, MRSA Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe MRSA Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 MRSA Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Tetracycline
1.2.2 Folate antagonist
1.2.3 Cephalosporin
1.2.4 Lipopeptides
1.2.5 Oxazolidinone
1.2.6 Lipoglycopeptide
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Research
1.3.3 Clinic
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 MRSA Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 MRSA Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 MRSA Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Theravance Biopharma
2.4.1 Business Overview
2.4.2 MRSA Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Theravance Biopharma MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Absynth Biologics
2.5.1 Business Overview
2.5.2 MRSA Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Absynth Biologics MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AmpliPhi Biosciences
2.6.1 Business Overview
2.6.2 MRSA Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AmpliPhi Biosciences MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 AstraZeneca
2.7.1 Business Overview
2.7.2 MRSA Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AstraZeneca MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Basilea Pharmaceutica
2.8.1 Business Overview
2.8.2 MRSA Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Basilea Pharmaceutica MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Baxter
2.9.1 Business Overview
2.9.2 MRSA Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Baxter MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cellceutix
2.10.1 Business Overview
2.10.2 MRSA Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cellceutix MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Cempra
2.11.1 Business Overview
2.11.2 MRSA Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Cempra MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 CrystalGenomics
2.12.1 Business Overview
2.12.2 MRSA Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 CrystalGenomics MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Debiopharm
2.13.1 Business Overview
2.13.2 MRSA Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Debiopharm MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Galapagos
2.14.1 Business Overview
2.14.2 MRSA Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Galapagos MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 GSK
2.15.1 Business Overview
2.15.2 MRSA Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 GSK MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 KYORIN Pharmaceutical
2.16.1 Business Overview
2.16.2 MRSA Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 KYORIN Pharmaceutical MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Lytix Biopharma
2.17.1 Business Overview
2.17.2 MRSA Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Lytix Biopharma MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Melinta Therapeutics
2.18.1 Business Overview
2.18.2 MRSA Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Melinta Therapeutics MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Nabriva Therapeutics
2.19.1 Business Overview
2.19.2 MRSA Drugs Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Nabriva Therapeutics MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 NovaDigm Therapeutics
2.20.1 Business Overview
2.20.2 MRSA Drugs Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 NovaDigm Therapeutics MRSA Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global MRSA Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global MRSA Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global MRSA Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 MRSA Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 MRSA Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global MRSA Drugs Market Analysis by Regions
4.1 Global MRSA Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global MRSA Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global MRSA Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America MRSA Drugs Sales and Growth Rate (2013-2018)
4.3 Europe MRSA Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific MRSA Drugs Sales and Growth Rate (2013-2018)
4.5 South America MRSA Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa MRSA Drugs Sales and Growth Rate (2013-2018)
5 North America MRSA Drugs by Countries
5.1 North America MRSA Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America MRSA Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America MRSA Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States MRSA Drugs Sales and Growth Rate (2013-2018)
5.3 Canada MRSA Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico MRSA Drugs Sales and Growth Rate (2013-2018)
6 Europe MRSA Drugs by Countries
6.1 Europe MRSA Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe MRSA Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe MRSA Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany MRSA Drugs Sales and Growth Rate (2013-2018)
6.3 UK MRSA Drugs Sales and Growth Rate (2013-2018)
6.4 France MRSA Drugs Sales and Growth Rate (2013-2018)
6.5 Russia MRSA Drugs Sales and Growth Rate (2013-2018)
6.6 Italy MRSA Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific MRSA Drugs by Countries
7.1 Asia-Pacific MRSA Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific MRSA Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific MRSA Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China MRSA Drugs Sales and Growth Rate (2013-2018)
7.3 Japan MRSA Drugs Sales and Growth Rate (2013-2018)
7.4 Korea MRSA Drugs Sales and Growth Rate (2013-2018)
7.5 India MRSA Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia MRSA Drugs Sales and Growth Rate (2013-2018)
8 South America MRSA Drugs by Countries
8.1 South America MRSA Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America MRSA Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America MRSA Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil MRSA Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina MRSA Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia MRSA Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa MRSA Drugs by Countries
9.1 Middle East and Africa MRSA Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa MRSA Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa MRSA Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia MRSA Drugs Sales and Growth Rate (2013-2018)
9.3 UAE MRSA Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt MRSA Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria MRSA Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa MRSA Drugs Sales and Growth Rate (2013-2018)
10 Global MRSA Drugs Market Segment by Type
10.1 Global MRSA Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global MRSA Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global MRSA Drugs Revenue and Market Share by Type (2013-2018)
10.2 Tetracycline Sales Growth and Price
10.2.1 Global Tetracycline Sales Growth (2013-2018)
10.2.2 Global Tetracycline Price (2013-2018)
10.3 Folate antagonist Sales Growth and Price
10.3.1 Global Folate antagonist Sales Growth (2013-2018)
10.3.2 Global Folate antagonist Price (2013-2018)
10.4 Cephalosporin Sales Growth and Price
10.4.1 Global Cephalosporin Sales Growth (2013-2018)
10.4.2 Global Cephalosporin Price (2013-2018)
10.5 Lipopeptides Sales Growth and Price
10.5.1 Global Lipopeptides Sales Growth (2013-2018)
10.5.2 Global Lipopeptides Price (2013-2018)
10.6 Oxazolidinone Sales Growth and Price
10.6.1 Global Oxazolidinone Sales Growth (2013-2018)
10.6.2 Global Oxazolidinone Price (2013-2018)
10.7 Lipoglycopeptide Sales Growth and Price
10.7.1 Global Lipoglycopeptide Sales Growth (2013-2018)
10.7.2 Global Lipoglycopeptide Price (2013-2018)
11 Global MRSA Drugs Market Segment by Application
11.1 Global MRSA Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Research Sales Growth (2013-2018)
11.4 Clinic Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 MRSA Drugs Market Forecast (2018-2023)
12.1 Global MRSA Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 MRSA Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America MRSA Drugs Market Forecast (2018-2023)
12.2.2 Europe MRSA Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific MRSA Drugs Market Forecast (2018-2023)
12.2.4 South America MRSA Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa MRSA Drugs Market Forecast (2018-2023)
12.3 MRSA Drugs Market Forecast by Type (2018-2023)
12.3.1 Global MRSA Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global MRSA Drugs Market Share Forecast by Type (2018-2023)
12.4 MRSA Drugs Market Forecast by Application (2018-2023)
12.4.1 Global MRSA Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global MRSA Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure MRSA Drugs Picture
Table Product Specifications of MRSA Drugs
Figure Global Sales Market Share of MRSA Drugs by Types in 2017
Table MRSA Drugs Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
